Trial Profile
Rheumatoid Arthritis Patients Treated With Tocilizumab in Real Clinical Practice: Effectiveness and Safety (TRUST Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TRUST
- Sponsors Roche
- 08 May 2017 Results published in the Clinical and Experimental Rheumatology Journal.
- 21 Jun 2016 Time frame for primary endpoint changed from 2 years to 12 months.
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.